BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2021
View Archived Issues
IL-27 drives metabolic programs and its targeting aids in the treatment of obesity
Read More
FBXO22 sensitizes tumor cells to DNA damage by PD-L1 degrading
Read More
Novel syngeneic bladder cancer model using organoid line with specific gene deletions
Read More
Ube Industries patents integrin alphav antagonists
Read More
Suzhou Zelgen Biosciences synthesizes new GTPase KRAS mutant inhibitors
Read More
Glixogen Therapeutics identifies GLI1 inhibitors
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group presents SOS1 inhibitors
Read More
Shanghai Zheye Biotechnology divulges new SGLT-1 inhibitors
Read More
RAGE-229 inhibits RAGE-DIAPH1 binding and lessens diabetic complications in mice
Read More
[68Ga]SP-94 shows excellent uptake in GRP78-positive HCC tumors
Read More
GP73 analysis aids in the diagnosis of NASH and staging of hepatic fibrosis
Read More
Targeting TWEAK shows potential as alternative therapeutic strategy for psoriasis
Read More
Oragenics reports on SARS-CoV-2 vaccine formulations in hamster challenge study
Read More
MALT1 mutant mice reveal role of E3 ligase TRAF6 in peripheral immune tolerance
Read More
Stepwise engineered IL-37-Fc-fusion protein shows improved therapeutic likeness
Read More
Small molecule allows targeted degradation of repeat expansion in vitro and in vivo in ALS models
Read More
Chimeric obtains option to license CORE-NK platform from Case Western Reserve University
Read More
DREADD approach calms neuropsychiatric dread circuits in primates
Read More